2024 Satellite Symposia Schedule

Satellite Symposia will be offered in the following times (subject to review and approval of content).


Monday, February 5, 2024, 6:15 AM – 7:15 AM
Patient-engagement in a New Digital World, from Diagnostics to Holistic Care
Sponsored by Sanofi
Click Here to Download Informational PDF

Monday, February 5, 2024, 11:45 AM – 12:45 PM
Unraveling the Enigma: Overcoming Challenges in ASMD Diagnosis and Management in the Real World
Sponsored by Sanofi
Click Here to Download Informational PDF

Monday, February 5, 2024, 11:45 AM – 12:45 PM
Momentum, Leadership & Diagnosis
Changing the paradigm for metachromatic leukodystrophy (MLD)
Sponsored by Orchard Therapeutics
Click Here to Download Informational PDF

Tuesday, February 6, 2024, 6:15 AM – 7:15 AM
Optimizing Outcomes in Late-Onset Pompe Disease: Integrating New Therapies, Whole-person Markers of Disease Monitoring, and Shared Decision-making into Practice
CE Satellite Symposium
Accredited provider: AKH Inc., Advancing Knowledge in Healthcare
Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC
Supported by an unrestricted educational grant from Amicus Therapeutics, Inc.
Click Here to Download Informational PDF

Tuesday, February 6, 2024, 6:15 AM – 7:15 AM
Fact or Fiction: The Facts on Treatment for Families with Fabry Disease
Sponsored by Sanofi
Click Here to Download Informational PDF

Tuesday, February 6, 2024, 11:45 AM – 12:45 PM
Gaucher Disease: The Evolving Big Picture
Part I: Unmet Needs and Redefining the GD Spectrum

CE Satellite Symposium
Accredited provider: Postgraduate Institute for Medicine (PIM)
Jointly provided by PIM and Saterdalen & Associates, LLC
Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Click Here to Download Informational PDF

Tuesday, February 6, 2024, 11:45 AM – 12:45 PM
From Bench to Bedside: the Example of Pompe Disease
Sponsored by Sanofi
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 6:15 AM – 7:15 AM
Advancing our knowledge of Galafold® (migalastat) treatment and monitoring strategies
Sponsored by Amicus Therapeutics
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 6:15 AM – 7:15 AM
Recognizing the Multisystemic Aspects of Pompe Disease and the Potential of Gene Therapy: A Conversation
Sponsored by Astellas Gene Therapies
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 11:45 AM – 12:45 PM
Gaucher Disease: The Evolving Big Picture
Part II: Gaucher Disease Across the Lifespan

CE Satellite Symposium
Accredited provider: Postgraduate Institute for Medicine (PIM)
Jointly provided by PIM and Saterdalen & Associates, LLC
Supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 11:45 AM – 12:45 PM
Moving forward together: Exploring a new treatment approach in LOPD
Sponsored by Amicus Therapeutics
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 5:15 PM – 6:15 PM
Perspectives on the Management of Fabry Disease
Sponsored by Chiesi Global Rare Diseases
Click Here to Download Informational PDF

Wednesday, February 7, 2024, 5:15 PM – 6:15 PM
From Prevailing to Pioneering: Current and Emerging Biomarkers in Neurodegenerative Lysosomal Diseases
Sponsored by Denali Therapeutics
Click Here to Download Informational PDF

Thursday, February 8, 2024, 6:15 AM – 7:15 AM
A Focus on Bone Manifestations in Gaucher Disease Type 1 Patients
Sponsored by Sanofi
Click Here to Download Informational PDF

Thursday, February 8, 2024, 6:15 AM – 7:15 AM
Patient Spotlight: Alpha-mannosidosis
Sponsored by Chiesi Global Rare Diseases
Click Here to Download Informational PDF

Thursday, February 8, 2024, 11:45 AM – 12:45 PM
Integrating New Evidence in Fabry Disease Monitoring and Management
Sponsored by Sanofi
This satellite is open only to registered attendees from outside the United States. International participants only.
Click Here to Download Informational PDF

Thursday, February 8, 2024, 11:45 AM – 12:45 PM
Neonatal Screening for lysosomal disorders: it is now time for clinical guidance
CE Satellite Symposium
Accredited provider: American Academy of CME, Inc.
Jointly provided by American Academy of CME, Inc., Lysosomal & Rare Disorders Research & Treatment Center (LDRTC), and CheckRare CE
Supported by educational grants from Chiesi and Takeda Pharmaceuticals. 
Click Here to Download Informational PDF

Thursday, February 8, 2024, 5:15 PM – 6:15 PM
Unlocking the power of the patient voice
Holistic care for patients with Fabry disease and alpha-mannosidosis

Sponsored by Chiesi Global Rare Diseases
Click Here to Download Informational PDF

Thursday, February 8, 2024, 5:15 PM – 6:15 PM
The Rare Disease Ecosystem at a Crossroads: Is There a Need for Convergence in the Use of Evidence for Decision-making in Health Care?
Sponsored by Sanofi
Click Here to Download Informational PDF


These Satellite Symposia are not part of the official WORLDSymposium™ program, and WORLDSymposium does not approve or endorse any commercial products or services discussed during the Satellite Symposia or offered for sale by any corporate supporter of the Satellite Symposia. These symposia may or may not offer CE credits; these sessions are not approved for CE through WORLDSymposium.

Eligibility: Registration for WORLDSymposium 2024 and an official name badge are required to attend satellite symposia.